209 related articles for article (PubMed ID: 30684529)
1. Hinokitiol suppresses growth of B16 melanoma by activating ERK/MKP3/proteosome pathway to downregulate survivin expression.
Wei KC; Chen RF; Chen YF; Lin CH
Toxicol Appl Pharmacol; 2019 Mar; 366():35-45. PubMed ID: 30684529
[TBL] [Abstract][Full Text] [Related]
2. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.
Huang CH; Lu SH; Chang CC; Thomas PA; Jayakumar T; Sheu JR
Eur J Pharmacol; 2015 Jan; 746():148-57. PubMed ID: 25449038
[TBL] [Abstract][Full Text] [Related]
3. Hinokitiol Exerts Anticancer Activity through Downregulation of MMPs 9/2 and Enhancement of Catalase and SOD Enzymes: In Vivo Augmentation of Lung Histoarchitecture.
Huang CH; Jayakumar T; Chang CC; Fong TH; Lu SH; Thomas PA; Choy CS; Sheu JR
Molecules; 2015 Sep; 20(10):17720-34. PubMed ID: 26404213
[TBL] [Abstract][Full Text] [Related]
4. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
Liu S; Yamauchi H
Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
[TBL] [Abstract][Full Text] [Related]
5. Hinokitiol increases the angiogenic potential of dental pulp cells through ERK and p38MAPK activation and hypoxia-inducible factor-1α (HIF-1α) upregulation.
Kim MK; Park HJ; Kim YD; Ryu MH; Takata T; Bae SK; Bae MK
Arch Oral Biol; 2014 Feb; 59(2):102-10. PubMed ID: 24370180
[TBL] [Abstract][Full Text] [Related]
6. Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells.
Tsao YT; Huang YF; Kuo CY; Lin YC; Chiang WC; Wang WK; Hsu CW; Lee CH
Int J Mol Sci; 2016 Feb; 17(2):248. PubMed ID: 26901194
[TBL] [Abstract][Full Text] [Related]
7. Hinokitiol reduces tumor metastasis by inhibiting heparanase via extracellular signal-regulated kinase and protein kinase B pathway.
Wu YJ; Hsu WJ; Wu LH; Liou HP; Pangilinan CR; Tyan YC; Lee CH
Int J Med Sci; 2020; 17(3):403-413. PubMed ID: 32132875
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer effects of CME-1, a novel polysaccharide, purified from the mycelia of Cordyceps sinensis against B16-F10 melanoma cells.
Jayakumar T; Chiu CC; Wang SH; Chou DS; Huang YK; Sheu JR
J Cancer Res Ther; 2014; 10(1):43-9. PubMed ID: 24762485
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of hinokitiol on tyrosinase activity and melanin biosynthesis and its antimicrobial activities.
Zhu YJ; Qiu L; Zhou JJ; Guo HY; Hu YH; Li ZC; Wang Q; Chen QX; Liu B
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):798-803. PubMed ID: 20578978
[TBL] [Abstract][Full Text] [Related]
10. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways.
Wu J; Xu J; Eksioglu EA; Chen X; Zhou J; Fortenbery N; Wei S; Dong J
Nutr Cancer; 2013; 65(1):110-7. PubMed ID: 23368920
[TBL] [Abstract][Full Text] [Related]
11. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
Chan DW; Liu VW; Tsao GS; Yao KM; Furukawa T; Chan KK; Ngan HY
Carcinogenesis; 2008 Sep; 29(9):1742-50. PubMed ID: 18632752
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative Activity of Hinokitiol, a Tropolone Derivative, Is Mediated via the Inductions of p-JNK and p-PLCγ1 Signaling in PDGF-BB-Stimulated Vascular Smooth Muscle Cells.
Yang PS; Wang MJ; Jayakumar T; Chou DS; Ko CY; Hsu MJ; Hsieh CY
Molecules; 2015 May; 20(5):8198-212. PubMed ID: 25961161
[TBL] [Abstract][Full Text] [Related]
13. Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via downregulation of NF-κB signaling pathway.
Lee KR; Lee JS; Kim YR; Song IG; Hong EK
Oncol Rep; 2014 May; 31(5):2447-53. PubMed ID: 24677090
[TBL] [Abstract][Full Text] [Related]
14. Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation.
Jurek A; Amagasaki K; Gembarska A; Heldin CH; Lennartsson J
J Biol Chem; 2009 Feb; 284(7):4626-34. PubMed ID: 19106095
[TBL] [Abstract][Full Text] [Related]
15. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of melanosomal proteins after hinokitiol treatment.
Choi YG; Bae EJ; Kim DS; Park SH; Kwon SB; Na JI; Park KC
J Dermatol Sci; 2006 Sep; 43(3):181-8. PubMed ID: 16781122
[TBL] [Abstract][Full Text] [Related]
17. Follicle-Stimulating Hormone (FSH)-dependent Regulation of Extracellular Regulated Kinase (ERK) Phosphorylation by the Mitogen-activated Protein (MAP) Kinase Phosphatase MKP3.
Donaubauer EM; Law NC; Hunzicker-Dunn ME
J Biol Chem; 2016 Sep; 291(37):19701-12. PubMed ID: 27422819
[TBL] [Abstract][Full Text] [Related]
18. Different Cell Responses to Hinokitiol Treatment Result in Senescence or Apoptosis in Human Osteosarcoma Cell Lines.
Yang SC; Chen HY; Chuang WL; Wang HC; Hsieh CP; Huang YF
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163553
[TBL] [Abstract][Full Text] [Related]
19. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
[TBL] [Abstract][Full Text] [Related]
20. Cycloartane triterpenoid (23R, 24E)-23-acetoxymangiferonic acid inhibited proliferation and migration in B16-F10 melanoma via MITF downregulation caused by inhibition of both β-catenin and c-Raf-MEK1-ERK signaling axis.
Kaneda T; Matsumoto M; Sotozono Y; Fukami S; Nugroho AE; Hirasawa Y; Hamid A HA; Morita H
J Nat Med; 2019 Jan; 73(1):47-58. PubMed ID: 30084054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
